Effectiveness of entecavir in preventing hepatocellular carcinoma development is genotype-dependent in hepatitis B virus-associated liver cirrhosis

Table 3 Comparison of initial hepatitis B virus deoxyribonucleic acid levels (log₁₀ IU/mL) between genotype C and D cirrhotic patients treated with entecavir

Main genotype	Ref.	Entecavir administered to HBV cirrhotic patientssis	Initial HBV DNA	Average
C	Su et al[8]	1315	5.5	5.61
C	Wong et al[1]	482	5.0
C	Watanabe et al[10]	86	6.4
C	Chen et al[9]	586	5.9
C	Chen et al[2]	61	5.8
C	Kim et al[5]	367	4.6
C	Choi et al[6]	510	6.7
D	Riveiro-Barciela et al[3]	64	4.9	5.46
D	Coffin et al[4]	25	6.5
D	Idilman et al[11]	72	5.5
D	Arends et al[13]	155	5.4
D	Köklü et al[12]	73	5.7

HBV DNA: Hepatitis B virus deoxyribonucleic acid.